• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ATLN:VX

85.850 CHF 0.150 0.18%

As of 11:43:58 ET on 04/17/2014.

Snapshot for Actelion Ltd (ATLN)

Open: 87.400 Day's Range: 85.500 - 87.950 Volume: 833,768
Previous Close: 85.700 52wk Range: 52.213 - 93.450 1-Yr Rtn: +62.23%

Stock Chart for ATLN

No chart data available.
  • ATLN:VX 85.850
  • 1D
  • 1M
  • 1Y
85.700
Interactive ATLN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATLN

Current P/E Ratio (ttm) 19.8268
Estimated P/E(12/2014) 19.3836
Relative P/E vs. SMI 1.0299
Earnings Per Share (CHF) (ttm) 4.3300
Est. EPS (CHF) (12/2014) 4.4290
Est. PEG Ratio 1.9653
Market Cap (M CHF) 10,325.69
Shares Outstanding (M) 120.28
30 Day Average Volume 507,908
Price/Book (mrq) 5.6369
Price/Sale (ttm) 5.2499
Dividend Indicated Gross Yield 1.40%
Cash Dividend (CHF) 1.2000
Dividend Ex-Date 05/12/2014
5 Year Dividend Growth -
Next Earnings Announcement 07/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATLN

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for ATLN

Actelion Ltd. is a pharmaceutical company that develops and markets synthetic small-molecule drugs against diseases related to the endothelium. The Company's drugs, Veletri and Tracleer, are used in the treatment of heart and pulmonary conditions.

Jean-Paul ClozelCEO/Co-FounderAndre C MullerChief Financial Officer
Otto SchwarzExec VP/COONicholas FrancoVP/Chief Bus Dev Officer
More Company Profile & Key Executives for ATLN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil